Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Abiraterone

An inhibitor of the CYP17 enzyme, blocking androgen production even outside the testes. Designed in the United Kingdom at the Institute of Cancer Research, it was approved in 2011 for advanced prostate cancer. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?The idea came from the antifungal ketoconazole, which blocked the same enzyme: in the 1995 scientific paper the new molecule appeared simply as 'compound 3'.

AbirateroneGo to the active ingredient →
AbirateroneActive ingredientAbirateroneCat. No. P-A006-001CAS 154229-19-3
Abiraterone-d4Isotopically labelledAbiraterone-d4Cat. No. P-A006-009CAS 2122245-62-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.